LINC00641 and neoplasm: As shown in (Figure 8a and b), DDP therapy or declination of LINC00641 gave rise to a decrease in tumor volume and weight, which indicated that DDP therapy or silenced LINC00641 repressed the growth of OS tumor in vivo.